Skip to main content
. Author manuscript; available in PMC: 2014 Jan 13.
Published in final edited form as: J Med Genet. 2013 Nov 19;51(1):55–60. doi: 10.1136/jmedgenet-2013-102000

Table 1. Summary results for the tested SNPs in 252 patients with unexplained adenomatous polyposis and 745 healthy controls.

Allele*
MAF
Chr SNP Base-pair position Minor Major Patients Controls p Value OR (95% CI) Gene Reference
1q41 rs6691170 222045446 T G 0.378 0.346 0.194 1.1 (0.9-1.4) DUSP10 CICP13 32
1q41 rs6687758 222164948 G A 0.228 0.197 0.141 1.2 (0.9 to 1.5) DUSP10 CICP14 32
3q26.2 rs10936599 169492101 T C 0.237 0.244 0.745 1.0 (0.8 to 1.2) MYNN 32
8q23.3 rs16892766 117630683 C A 0.086 0.086 0.998 1.0 (0.7 to 1.4) TRPS1 EIF3H 33
8q24.21 rs6983267 128413305 G T 0.575 0.530 0.078 1.2 (1.0 to 1.5) POU5F1 MYC 34
10p14 rs10795668 8701219 A G 0.290 0.324 0.154 0.9 (0.7 to 1.1) KRT8P16 TCEB1P3 33
11q23 rs3802842 111171709 C A 0.355 0.256 0.00002 1.6 (1.3 to 2.0) C11orf93 11
12q13.13 rs7136702 50880216 T C 0.357 0.327 0.222 1.1 (0.9 to 1.4) TBX3 UBA52P7 32
12q13.13 rs11169552 51155663 T C 0.260 0.264 0.876 1.0 (0.8 to 1.2) DIP2B ATF1 32
14q22.2 rs4444235 54410919 C T 0.444 0.437 0.763 1.0 (0.8 to 1.3) RPS3AP46 BMP4 12
15q13 rs4779584 32994756 T C 0.256 0.187 0.001 1.5 (1.2 to 1.9) SCG5 GREM1
FMN1 CRAC1
35
16q22.1 rs9929218 68820946 A G 0.280 0.278 0.921 1.0 (0.8 to 1.3) CDH1 12
18q21.1 rs4939827 46453463 C T 0.486 0.491 0.864 1.0 (0.8 to 1.2) SMAD7 14
19q13.1 rs10411210 33532300 T C 0.090 0.092 0.918 1.0 (0.7 to 1.4) RHPN2 12
20p12.3 rs961253 6404281 A C 0.386 0.375 0.661 1.0 (0.9 to 1.3) TARDBPL BMP2 12
20q13.33 rs4925386 60921044 T C 0.297 0.316 0.423 0.9 (0.7 to 1.1) LAMA5 32
*

For SNP rs6983267, the minor allele originally reported (G) is the most frequent allele, both in our cases and controls.

The SNP positions are according to Human Build 36.3.

Chr, chromosome; MAF, minor allele frequency.